Toll Free: 1-888-928-9744
Published: Jul, 2015 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Stelic Institute & Co. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Stelic Institute & Co. - Product Pipeline Review - 2015', provides an overview of the Stelic Institute & Co.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Stelic Institute & Co.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Stelic Institute & Co. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Stelic Institute & Co.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Stelic Institute & Co.'s pipeline products Reasons to buy - Evaluate Stelic Institute & Co.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Stelic Institute & Co. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Stelic Institute & Co.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Stelic Institute & Co. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stelic Institute & Co. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Stelic Institute & Co. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Stelic Institute & Co. Snapshot 5 Stelic Institute & Co. Overview 5 Key Information 5 Key Facts 5 Stelic Institute & Co. - Research and Development Overview 6 Key Therapeutic Areas 6 Stelic Institute & Co. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Stelic Institute & Co. - Pipeline Products Glance 10 Stelic Institute & Co. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Stelic Institute & Co. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 Stelic Institute & Co. - Drug Profiles 13 STNM-01 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 STNM-04 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Small Molecule to Inhibit Glycogene 1 for Parkinson's Disease 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecule to Inhibit Glycogene 5 for Dementia 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 STNM-03 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 STNM-06 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 STNM-09 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 STNM-1510 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 STNM-310 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Stelic Institute & Co. - Pipeline Analysis 22 Stelic Institute & Co. - Pipeline Products by Target 22 Stelic Institute & Co. - Pipeline Products by Route of Administration 23 Stelic Institute & Co. - Pipeline Products by Molecule Type 24 Stelic Institute & Co. - Pipeline Products by Mechanism of Action 25 Stelic Institute & Co. - Dormant Projects 26 Stelic Institute & Co. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Stelic Institute & Co., Key Information 5 Stelic Institute & Co., Key Facts 5 Stelic Institute & Co. - Pipeline by Indication, 2015 7 Stelic Institute & Co. - Pipeline by Stage of Development, 2015 8 Stelic Institute & Co. - Monotherapy Products in Pipeline, 2015 9 Stelic Institute & Co. - Phase II, 2015 10 Stelic Institute & Co. - Preclinical, 2015 11 Stelic Institute & Co. - Discovery, 2015 12 Stelic Institute & Co. - Pipeline by Target, 2015 22 Stelic Institute & Co. - Pipeline by Route of Administration, 2015 23 Stelic Institute & Co. - Pipeline by Molecule Type, 2015 24 Stelic Institute & Co. - Pipeline Products by Mechanism of Action, 2015 25 Stelic Institute & Co. - Dormant Developmental Projects,2015 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.